Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

Arteriosclerosis Thrombosis and Vascular Biology(2023)10.1161/atvbaha.123.319385Source: DataRank Database

ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia is a research paper published in Arteriosclerosis Thrombosis and Vascular Biology (2023). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

geo gen uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 4.50)OA: bronzeTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Jenna C. Pucel,Aya Nomura-Kitabayashi ORCID,Pallavi Chandakkar,Adella P. Guidroz ORCID,Nikita L. Jhangiani ORCID

Live enrichment

PubMed:37288572 PMC:PMC10524982 OpenAlex:https://openalex.org/W4379768567

NHLBI NIH HHS

Grant: R01 HL163196

NHLBI NIH HHS

Grant: R01 HL150040

NHLBI NIH HHS

Grant: R01 HL139778

NIDDK NIH HHS

Grant: P30 DK114857

NHLBI NIH HHS

Grant: R01 HL139713

American Heart Association-American Stroke Association

Grant: 20PRE35120237

FWCI

4.50

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronze

journalhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.123.319385

publisherhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.123.319385

publisherhttps://www.ahajournals.org/doi/full/10.1161/ATVBAHA.123.319385

journalhttps://doi.org/10.1161/atvbaha.123.319385

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37288572

Fields of Study

Vascular Anomalies and TreatmentsVascular Malformations and HemangiomasVascular Malformations Diagnosis and Treatment

MeSH Terms

AnimalsArteriovenous MalformationsPhenotypeTelangiectasia, Hereditary HemorrhagicAngiopoietin-2Endothelial CellsMice

Keywords

Downregulation and upregulationAngiogenesisArteriovenous malformationAngiopoietin receptorTelangiectasiaBlockadeAngiopoietinTranscriptomeMedicineCancer researchReceptorPathologyBiologyGeneInternal medicineGene expressionGeneticsVascular endothelial growth factorVEGF receptorsBrainendothelialArteriovenous Malformations

Sustainable Development Goals

SDG 0: Good health and well-being

ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

FAIR Checklist

Authors (13)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)